Delaet Ingrid

CIK 00019658081 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001965808

Recent Transactions

50 trades

Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-07-10$79.02/sh+457→ 5,187 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-07-10$135.00/sh−457→ 4,730 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2025-07-10−457→ 2,261 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-13−1,401→ 4,203 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13$116.72/sh−755→ 4,730 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-13−1,358→ 2,718 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13+1,401→ 5,485 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13$116.69/sh−716→ 4,084 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13+1,358→ 4,800 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2025-02-12+34,153→ 34,153 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-12+6,401→ 6,401 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-03−1,179→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-03+1,179→ 4,065 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-03$149.29/sh−623→ 3,442 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restriced Stock Unit
2025-01-31−801→ 801 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-31$153.05/sh−422→ 2,886 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-31+801→ 3,308 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-12-31$79.02/sh+272→ 2,779 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-12-31$138.10/sh−272→ 2,507 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-12-31−272→ 2,718 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-12-17$135.00/sh−1,091→ 2,507 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-12-17$79.02/sh+1,091→ 3,598 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-12-17−1,091→ 2,990 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-08-13$103.52/sh+3,043→ 9,650 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-08-13−3,043→ 22,049 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-08-13$150.13/sh−3,043→ 6,607 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-08-13$150.08/sh−4,100→ 2,507 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-08-06$147.70/sh−273→ 6,607 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-08-06$79.02/sh+273→ 6,880 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-08-06−273→ 4,081 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-07-16$103.52/sh+400→ 7,907 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-07-16−1,557→ 25,092 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-07-16−400→ 26,649 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-07-16$103.52/sh+1,557→ 9,064 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-07-16$150.04/sh−900→ 6,607 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-07-16$150.10/sh−400→ 7,507 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-07-16$150.00/sh−1,557→ 7,507 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-07-01−272→ 4,354 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-07-01$138.11/sh−272→ 7,507 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-07-01$79.02/sh+272→ 7,779 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-05-31−273→ 4,626 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-31$79.02/sh+273→ 7,780 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-31$136.55/sh−273→ 7,507 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-05-06$79.02/sh−273→ 4,899 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-06$140.55/sh−273→ 7,507 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-06$79.02/sh+273→ 7,780 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-04-01$79.02/sh−272→ 5,172 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-04-01$79.02/sh+272→ 7,779 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-04-01$137.30/sh−272→ 7,507 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-03-21$145.06/sh−5,000→ 7,507 total

Companies

NEUROCRINE BIOSCIENCES INC
Chief Regulatory Officer
$NBIX

Recent Filings

Address

12780 EL CAMINO REAL

SAN DIEGO, CA, 92130

View on SEC.gov